UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
--------------------------------- ---------------------------------
FORM 4 OMB APPROVAL
--------------------------------- ---------------------------------
OMB Number: 3235-0287
[X] Check this box if no longer Expires: January 31, 2005
subject to Section 16. Form 4 Estimated average burden
or Form 5 obligations may hours per response..........1.0
continue. See Instruction 1(b). ---------------------------------
(Print or Type Responses)
----------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol
Pharmacia Corporation Monsanto Company (MON)
----------------------------------------------------------------------------------------------------------------------------
(Last) (First) (Middle) 3. I.R.S. Identification 4. Statement for
Number of Reporting Month/Year
Person, if an entity
100 Route 206 North (Voluntary) August 2002
-------------------------------------------------- ---------------------------------
(Street) 5. If Amendment, Date of
Peapack NJ 07977 Original (Month/Year)
--------------------------------------------------
(City) (State) (Zip)
----------------------------------------------------------------------------------------------------------------------------
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
--- ---
Officer (give Other (specify
--- title below) --- below)
----------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
X Form Filed by One Reporting Person
---
Form Filed by More than One Reporting Person
---
----------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
-----------------------------------------------------------------------------------------------------------
1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired (A)
(Instr. 3) action action or Disposed of (D)
Date Code (Instr. 3, 4 and 5)
(Instr. 8)
(Month/ ------------------------------------------------------
Day/
Year)
Amount (A) or
Code V (D) Price
-----------------------------------------------------------------------------------------------------------
Common Stock 8/13/02 J(1) 220,000,000 D --
-----------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------
-------------------------------------------------------------
5. Amount of 6. Owner- 7. Nature of
Securities Bene- ship Indirect
ficially Owned Form: Beneficial
at End of Direct Owner-
Month (D) or ship
Indirect
(Instr. 3 and 4) (I)
(Instr. 4) (Instr. 4)
-------------------------------------------------------------
0 D --
-------------------------------------------------------------
-------------------------------------------------------------
-------------------------------------------------------------
-------------------------------------------------------------
-------------------------------------------------------------
Reminder: Report on a separate line for each class of securities
beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see (Over)
Instruction 4(b)(v). SEC 1474 (7-97)
FORM 4 (continued)
Table II-- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
--------------------------------------------------------------------------------------------------------------------
1. Title of Derivative 2. Conver- 3. Trans- 4. Transac- 5. Number of Deriv- 6. Date Exer-
Security sion or action tion Code ative Securities Ac- cisable and Ex-
(Instr. 3) Exercise Date (Instr. 8) quired (A) or Dis- piration Date
Price of posed of (D) (Month/Day/
Deriv- (Month/ (Instr. 3, 4, and 5) Year)
ative Day/
Security Year) ------------------------------------------------------------------
Date Expira-
Exer- tion
Code V (A) (D) cisable Date
--------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
7. Title and Amount of Under- 8. Price 9. Number 10. Owner- 11. Nature
lying Securities of of ship of
(Instr. 3 and 4) deriv- Deriv- Form of Indirect
ative ative Deriv- Benefi-
Secu- Secu- ative cial
rity rities Secu- Owner-
------------------------------ (Instr. 5) Bene- rity: ship
ficially Direct (Instr. 4)
Owned (D) or
at End Indi-
of rect(I)
Month (Instr. 4)
(Instr. 4)
Title Amount or
Number of
Shares
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
Explanation of Responses:
(1) On August 13, 2002, Pharmacia Corporation (NYSE: PHA) ("Pharmacia")
spun-off its remaining interest in its agricultural subsidiary, Monsanto
Company (NYSE: MON) ("Monsanto"), to the holders of Pharmacia common
stock. The spin-off was effected by a special stock dividend, in the
aggregate, of 220,000,000 shares of Monsanto common stock resulting in a
distribution ratio of 0.170593 of a share of Monsanto common stock for
each outstanding share of Pharmacia common stock. The dividend was paid
on August 13, 2002 to holders of record of shares of Pharmacia common
stock that were issued and outstanding as of 5:00 p.m. Eastern time on
July 29, 2002, the record date.
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
/s/ Don W. Schmitz 08/21/02
----------------------------------- --------------
**Signature of Reporting Person Date
Don W. Schmitz
Vice President and Secretary
Pharmacia Corporation
Page 2 of 2
SEC 1474 (7-97)
(Print or Type Response)